Taking pulse on private biotech funding; Q&A with Isomorphic Labs CEO; Research institutions rethinks dealmaking; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
The first edition of Lydia Ramsey Pflanzer’s brand new newsletter, Endpoints Health Tech, is out! It marks our first foray outside the world of biopharma, and promises to complement our current coverage. Check out the launch note, where Lydia lays out her vision and the themes she’s watching.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.